Secondary Logo

Journal Logo

September 2010 - Volume 33 - Issue 7
pp: 659-741

Meeting Report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010

Lesinski, Gregory B.; Carson, William E.; Repasky, Elizabeth A.; More

Journal of Immunotherapy. 33(7):659-662, September 2010.


Cord Blood Natural Killer Cells Exhibit Impaired Lytic Immunological Synapse Formation That Is Reversed With IL-2 Exvivo Expansion

Xing, Dongxia; Ramsay, Alan G.; Gribben, John G.; More

Journal of Immunotherapy. 33(7):684-696, September 2010.

Selective Transduction of Dendritic Cells in Human Lymph Nodes and Superior Induction of High-avidity Melanoma-reactive Cytotoxic T Cells by a CD40-targeted Adenovirus

Hangalapura, Basav N.; Oosterhoff, Dinja; Aggarwal, Shikhar; More

Journal of Immunotherapy. 33(7):706-715, September 2010.



A Pilot Study of Denileukin Diftitox (DD) in Combination With High-dose Interleukin-2 (IL-2) for Patients With Metastatic Renal Cell Carcinoma (RCC)

Atchison, Elizabeth; Eklund, John; Martone, Brenda; More

Journal of Immunotherapy. 33(7):716-722, September 2010.

Impact of 3 Different Short-term Chemotherapy Regimens on Lymphocyte-depletion and Reconstitution in Melanoma Patients

Laurent, Julien; Speiser, Daniel E.; Appay, Victor; More

Journal of Immunotherapy. 33(7):723-734, September 2010.

Dose-finding Trial of a Combined Regsimen With Bevacizumab, Immunotherapy, and Chemotherapy in Patients With Metastatic Renal Cell Cancer: An Italian Oncology Group for Clinical Research (GOIRC) Study

Buti, Sebastiano; Lazzarelli, Silvia; Chiesa, Matteo Dalla; More

Journal of Immunotherapy. 33(7):735-741, September 2010.